Things Are Looking Up On The US Regulatory/Policy Front
Going in to 2016, it's hard not to characterize the US regulatory and policy environment as positive for the medical device industry. There is a consensus that the FDA premarket review process in 2015 has become, on average, more efficient and more transparent that it was five to 10 years ago. And policymakers, if anything, are focused on furthering that trend.
Register for our free email digests: